Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF | V.TLT.W

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by wildbird1on Apr 05, 2024 10:46am
276 Views
Post# 35972673

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:News ! Vaccine patent

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:News ! Vaccine patent
jewel9m wrote: Rogers is the largest share holder. He is not going to reverse split unless it directly benifits the share price. 


Jewel9m & StevenBirch I agree ...
Every time the SP stabilize somebody come up with a reverse split doomsday scenario.

1) As you said ''Jewel9m'' R.Dumoulin and friends have to much to lose in a reverse split.
2) With multiple cancer treatments on the table(bladder,brain,lungs...) over 300 million shares out is a puny little number of shares.
3) When TLT will get approval for more than one cancer treatment, the SP will easily climb in the $30 US range, and $30.US is in the range of a stock split not of a reverse split.
ex;(of stock split) If you have say 100k TLT shares at $30.US,and TLT does a 3/1 stock split you end up having 300k shares at $10US each.
4) A stock split intentionally lower the price of a single share, making the company stock more affordable without loosing value.
5) In short, more peoples can afford to buy TLT share at $10US and consequently the SP start to climb again toward the $30.US range, and you end up with another 3/1 stock split.

We are not there yet, but nothing wrong with dreaming.

Until then we have to live with the doomsday reverse split boys.

<< Previous
Bullboard Posts
Next >>